Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Future Medicinal Chemistry|September 19, 2019
Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-dionesBojan P Bondžić, Zdravko Džambaski, Ana Kolarević, et al.
Chemmedchem|January 5, 2019
An Overview, Advantages and Therapeutic Potential of Nonpeptide Positive Allosteric Modulators of Glucagon-Like Peptide-1 ReceptorAndrija Smelcerovic, Jelena Lazarevic, Katarina Tomovic, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
New biologically active epidioxysterols from Stereum hirsutumFrancesca Cateni, Bojan Doljak, Marina Zacchigna, et al.
RSC Advances|July 21, 2025
OSMI-4-based PROTACs do not influence <i>O</i>-GlcNAc transferase and <i>O</i>-GlcNAcylation levels in cellsAleša Bricelj, Doroteja Novak, Lara Smrdel, et al.
Chemico-Biological Interactions|January 27, 2015
Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-onesZaklina Smelcerovic, Andrej Veljkovic, Gordana Kocic, et al.
Future Medicinal Chemistry|May 30, 2019
Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragmentsAnja Kolarič, Doroteja Novak, Matjaž Weiss, et al.
F1000Research|May 23, 2017
A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy dietVeljko Veljkovic, Vladimir Perovic, Marko Anderluh, et al.
Molecular Diversity|November 16, 2010
Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonistsNataša Obermajer, Sara Sattin, Cinzia Colombo, et al.
Current Topics in Medicinal Chemistry|June 20, 2015
An overview of recent dipeptidyl peptidase-IV inhibitors: linking their structure and physico-chemical properties with sar, pharmacokinetics and toxicityAndrija Smelcerovic, Filip Miljkovic, Ana Kolarevic, et al.
Pageof 9